SEATTLE (AP) — SEATTLE (AP) — Perspective Therapeutics, Inc. (CATX) on Tuesday reported a loss of $15.1 million in its third quarter.
On a per-share basis, the Seattle-based company said it had a loss of 21 cents.
The results matched Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was also for a loss of 21 cents per share.
The isotope-based medical products maker posted revenue of $369,000 in the period.
Perspective Therapeutics shares have more than doubled since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $10.75, more than quadrupling in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CATX at https://www.zacks.com/ap/CATX
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.